GBT is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of sickle cell diseases.
Business Model:
Revenue: $234.9M
Employees: 201-500
Address: 181 Oyster Point Boulevard
City: South San Francisco
State: CA
Zip: 94080
Country: US
GBT is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of sickle cell diseases.
Contact Phone:
+18334282677
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/21/2015
IPO Valuation:
$540M
Ticker Symbol:
GBT
IPO Price:
$20/share
Amount Raised:
$120M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2014 | Equity | $48M |
Third Rock Ventures |
7/2015 | IPO | $115M | 12/2019 | Debt | $150M |
Pharmakon Advisors Lp |
2/2017 | Post-IPO Equity | $143.8M | 1/2015 | Series B | 4 | $48M |
Sabby Capital Wellington Management RA Capital Management Deerfield Sabby Capital Wellington Management RA Capital Management Deerfield |
12/2021 | Post-IPO Debt | $300M | 6/2012 | Series A | 1 | $40.7M |
Third Rock Ventures Third Rock Ventures Third Rock Ventures Third Rock Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|